Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-20 Purchase |
2024-03-25 11:05 am |
Cyteir Therapeutics Inc. | CYT | Leonard Braden Michael 10% Owner |
170,589 | $2.95 | $503,238 | 3,989,053 (Indirect Direct) |
View |
| 2024-03-18 Purchase |
2024-03-19 4:19 pm |
Cyteir Therapeutics Inc. | CYT | Leonard Braden Michael 10% Owner |
113,777 | $3.01 | $342,469 | 3,818,464 (Indirect Direct) |
View |
| 2023-07-19 Sale |
2023-07-20 8:01 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
101,900 | $2.7516 | $280,387 | 3,522,136 (Direct) |
View |
| 2023-07-14 Sale |
2023-07-18 8:27 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
38,600 | $2.7467 | $106,024 | 3,624,036 (Direct) |
View |
| 2023-06-30 Sale |
2023-07-03 6:29 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
200,937 | $2.6341 | $529,288 | 3,662,636 (Direct) |
View |
| 2023-06-26 Sale |
2023-06-28 9:35 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
40,415 | $1.7764 | $71,794 | 3,863,573 (Direct) |
View |
| 2023-06-21 Sale |
2023-06-23 7:17 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
13,298 | $1.9454 | $25,870 | 3,903,988 (Direct) |
View |
| 2023-06-15 Sale |
2023-06-20 5:53 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
16,729 | $2.0335 | $34,019 | 3,917,286 (Direct) |
View |
| 2023-06-12 Sale |
2023-06-14 8:18 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
6,398 | $2.098 | $13,423 | 3,934,015 (Direct) |
View |
| 2022-12-07 Purchase |
2022-12-08 5:09 pm |
Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director |
21,202 | $1.3 | $27,563 | 362,340 (Indirect Direct) |
View |
| 2022-07-20 Sale |
2022-07-22 6:52 pm |
Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner |
900,000 | $3 | $2,700,000 | 3,940,413 (Direct) |
View |
| 2022-05-12 Purchase |
2022-05-16 4:24 pm |
Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director |
743 | $1.61 | $1,196 | 341,138 (Indirect Direct) |
View |
| 2022-05-10 Purchase |
2022-05-12 4:38 pm |
Cyteir Therapeutics Inc. | CYT | THERO JOHN F Director |
10,000 | $2 | $20,000 | 10,000 (Direct) |
View |
| 2022-05-10 Purchase |
2022-05-12 4:35 pm |
Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director |
50,406 | $1.8862 | $95,077 | 340,395 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-03-19 4:09 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Leonard Braden Michael 10% Owner |
0 | $0 | 3,704,687 (Indirect) |
View |
| 2024-02-29 Exercise |
2024-03-05 6:11 pm |
N/A 2030-12-10 |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
10,358 | $0 | 287,064 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-05 6:11 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
3,239 | $1.68 | 287,064 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-05 6:11 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
7,119 | $1.69 | 287,064 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-05 6:10 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
21,448 | $0 | 1,551,261 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-05 6:10 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
2,537 | $1.2 | 1,551,261 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-05 6:10 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
18,911 | $1.69 | 1,551,261 (Direct) |
View |
| 2024-02-14 Exercise |
2024-02-16 4:00 pm |
2024-02-03 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | George Jean Director |
14,150 | $0 | 2,458,415 (Direct) |
View |
| 2024-02-14 Exercise |
2024-02-16 4:00 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | George Jean Director |
14,150 | $1.69 | 2,458,415 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-14 4:01 pm |
2024-02-03 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | Sands Stephen H. Director |
12,129 | $0 | 12,129 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-14 4:01 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Sands Stephen H. Director |
12,129 | $1.69 | 12,129 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 4:00 pm |
2024-02-03 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | THERO JOHN F Director |
12,828 | $0 | 22,828 (Direct) |
View |
| 2024-02-08 Exercise |
2024-02-12 4:00 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | THERO JOHN F Director |
12,828 | $1.69 | 22,828 (Direct) |
View |
| 2024-02-06 Exercise |
2024-02-08 4:11 pm |
2024-02-03 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director |
14,150 | $0 | 376,490 (Direct) |
View |
| 2024-02-06 Exercise |
2024-02-08 4:11 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director |
14,150 | $1.69 | 376,490 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-14 4:00 pm |
N/A 2030-12-10 |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
3,993 | $0 | 201,639 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-14 4:00 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
1,620 | $1.68 | 201,639 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-14 4:00 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
2,373 | $1.69 | 201,639 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-14 4:00 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
8,840 | $0 | 1,324,309 (Direct) |
View |
| 2023-11-20 Exercise |
2023-12-14 4:00 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
2,536 | $1.2 | 1,324,309 (Direct) |
View |
| 2023-11-20 Exercise |
2023-12-14 4:00 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
6,304 | $1.69 | 1,324,309 (Direct) |
View |
| 2023-11-20 Exercise |
2023-11-22 1:48 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
84,637 | $0 | 1,324,309 (Direct) |
View |
| 2023-11-20 Exercise |
2023-11-22 1:48 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
27,900 | $1.2 | 1,324,309 (Direct) |
View |
| 2023-11-20 Exercise |
2023-11-22 1:48 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
56,737 | $1.69 | 1,324,309 (Direct) |
View |
| 2023-11-20 Exercise |
2023-11-22 1:47 pm |
N/A 2030-12-10 |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
73,940 | $0 | 201,639 (Direct) |
View |
| 2023-11-20 Exercise |
2023-11-22 1:47 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
52,584 | $1.68 | 201,639 (Direct) |
View |
| 2023-11-20 Exercise |
2023-11-22 1:47 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
21,356 | $1.69 | 201,639 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:48 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director |
14,150 | $0 | 14,150 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:47 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | THERO JOHN F Director |
12,828 | $0 | 12,828 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:46 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | Sands Stephen H. Director |
12,129 | $0 | 12,129 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:45 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | Romberger Timothy Director |
14,150 | $0 | 14,150 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:44 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | Molineaux Susan Director |
14,150 | $0 | 14,150 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:43 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | Humphrey Jeffrey Director |
14,150 | $0 | 14,150 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:42 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | George Jean Director |
14,150 | $0 | 14,150 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:42 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | Bracken Racquel Director |
14,150 | $0 | 14,150 (Direct) |
View |
| 2023-01-13 Option Award |
2023-02-07 4:41 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
5,000 | $1.49 | 123,000 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:41 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
113,900 | $0 | 123,000 (Direct) |
View |
| 2021-12-20 Exercise |
2023-02-07 4:38 pm |
N/A 2030-12-10 |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
4,100 | $0 | 77,739 (Direct) |
View |
| 2021-12-20 Exercise |
2023-02-07 4:38 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer |
4,100 | $1.68 | 77,739 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:14 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | Veness Adam M General Counsel |
96,100 | $0 | 96,100 (Direct) |
View |
| 2023-01-13 Option Award |
2023-02-07 4:08 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
5,000 | $1.49 | 1,286,336 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:08 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
302,600 | $0 | 1,286,336 (Direct) |
View |
| 2022-12-21 Exercise |
2022-12-23 4:47 pm |
N/A 2028-12-10 |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
136,782 | $0 | 1,011,709 (Direct) |
View |
| 2022-12-21 Exercise |
2022-12-23 4:47 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
30,437 | $1.2 | 1,011,709 (Direct) |
View |
| 2022-12-21 Exercise |
2022-12-23 4:47 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
106,345 | $1.03 | 1,011,709 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 4:22 pm |
N/A 2032-04-25 |
Cyteir Therapeutics Inc. | CYT | Veness Adam M General Counsel |
177,000 | $0 | 177,000 (Direct) |
View |